TTD | Drug: D0GP8N

Drug General Information
Drug ID	D0GP8N
Former ID	DNCL002353
Drug Name	MK-8808
Indication	Late-stage follicular lymphoma [ICD9: 202.0, 202.8; ICD10:C81-C86, C82]		Phase 3	[549266]
Indication	Rheumatoid arthritis [ICD9: 710-719, 714; ICD10:M05-M06]		Phase 1	[549266]
Company	Merck
Target and Pathway
Target(s)	B-lymphocyte antigen CD20	Target Info	Agonist	[526862]
KEGG Pathway	Hematopoietic cell lineage
References
Ref 549266	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800034367)
Ref 526862	Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance. Oncogene. 2003 Oct 20;22(47):7359-68.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.

Drug Information